2010 saw the publication of a number of papers that provide new information on the relationship between blood pressure and the kidney. The data reinforce the need for future studies to jointly consider cardiovascular and renal outcomes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375, 2073–2081 (2010).
Sehestedt, T. et al. Risk prediction is improved by adding markers of subclinical organ damage to score. Eur. Heart J. 31, 883–891 (2010).
Bakris, G. et al. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 375, 1140–1142 (2010).
Weber, M. A. et al. Cardiovascular events during differing hypertension therapies in patients with diabetes. J. Am. Coll. Cardiol. 56, 77–85 (2010).
Mann, J. A. F. et al. Avosentan for overt diabetic nephropathy. J. Am. Soc. Nephrol. 21, 527–535 (2010).
De Zeeuw, D. et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376, 1543–1551 (2010).
Appel, L. J. et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N. Engl. J. Med. 363, 918–929 (2010).
Ritz, E. & Wenzel, R. Endothelin receptor antagonists in proteinuric renal disease: every rose has its thorn. J. Am. Soc. Nephrol. 21, 383–394 (2010).
Lewis, J. B. Blood pressure control in chronic kidney disease: is less really more? J. Am. Soc. Nephrol. 21, 1086–1092 (2010).
Cushman, W. C. et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med. 362, 1575–1585 (2010).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Ruilope, L. Blood pressure and the kidney. Nat Rev Nephrol 7, 73–74 (2011). https://doi.org/10.1038/nrneph.2010.189
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2010.189
This article is cited by
-
Pathophysiology of Hypertension in the Absence of Nitric Oxide/Cyclic GMP Signaling
Current Hypertension Reports (2013)
